Login / Signup

The prognostic value of IKZF1 plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.

Michal KicinskiChloé ArfeuilleNathalie GrardelMarleen BakkusAurélie Caye-EudeGeneviève PlatAlina FersterAnne UyttebroeckBarbara De MoerloosePierre RohrlichStefan SuciuYves BertrandHélène Cave
Published in: Pediatric blood & cancer (2023)
was not statistically significant.
Keyphrases
  • acute lymphoblastic leukemia
  • phase iii
  • allogeneic hematopoietic stem cell transplantation
  • study protocol
  • phase ii
  • clinical trial
  • randomized controlled trial
  • open label
  • cell fate
  • double blind